Top 5 HIV PrEP stories from CROI 2024
Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment
Huge increase in PrEP uptake when services offer choice, flexibility and injectable PrEP, African study shows
PrEP marketing should not be a story about HIV, but a story about young women
Zimbabwe shows how to make new HIV prevention products available quickly
Top 5 HIV PrEP stories from IAS 2023
Injectable PrEP requires new testing procedures, IAS conference hears
Two modelling studies ask: will injectable PrEP ever be cost-effective at achievable prices?
Top 5 stories on injectable HIV treatment and PrEP from CROI 2023
